Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15375)

• Formulation Name: Nilutamide 150 mg tablet
• Company: Sanofi-Aventis

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Nilutamide	(DMFN07X)	Prostate cancer	2C82.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Docusate sodium	(E00563)	23673837	Surfactant
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant